BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaplowitz N. Drug-induced liver disorders: implications for drug development and regulation. Drug Saf. 2001;24:483-490. [PMID: 11444721 DOI: 10.2165/00002018-200124070-00001] [Cited by in Crossref: 178] [Cited by in F6Publishing: 150] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Hadi M, Chen Y, Starokozhko V, Merema MT, Groothuis GM. Mouse Precision-Cut Liver Slices as an ex Vivo Model To Study Idiosyncratic Drug-Induced Liver Injury. Chem Res Toxicol 2012;25:1938-47. [DOI: 10.1021/tx300248j] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
2 Caplin JD, Granados NG, James MR, Montazami R, Hashemi N. Microfluidic Organ-on-a-Chip Technology for Advancement of Drug Development and Toxicology. Adv Healthcare Mater 2015;4:1426-50. [DOI: 10.1002/adhm.201500040] [Cited by in Crossref: 113] [Cited by in F6Publishing: 87] [Article Influence: 16.1] [Reference Citation Analysis]
3 Sandhu N, Navarro V. Drug-Induced Liver Injury in GI Practice. Hepatol Commun. 2020;4:631-645. [PMID: 32363315 DOI: 10.1002/hep4.1503] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
4 Maioli MA, de Medeiros HC, Guelfi M, Trinca V, Pereira FT, Mingatto FE. The role of mitochondria and biotransformation in abamectin-induced cytotoxicity in isolated rat hepatocytes. Toxicol In Vitro 2013;27:570-9. [PMID: 23142325 DOI: 10.1016/j.tiv.2012.10.017] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
5 Kneiseler G, Bachmann HS, Bechmann LP, Dechene A, Heyer T, Baba H, Saner F, Jochum C, Gerken G, Canbay A. A Rare Case of Propofol-Induced Acute Liver Failure and Literature Review. Case Rep Gastroenterol 2010;4:57-65. [PMID: 21103229 DOI: 10.1159/000262448] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
6 Kabbara WK, Sarkis AT, Saroufim PG. Acute and Fatal Isoniazid-Induced Hepatotoxicity: A Case Report and Review of the Literature. Case Rep Infect Dis 2016;2016:3617408. [PMID: 27648319 DOI: 10.1155/2016/3617408] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
7 Zhou S, Chan E, Duan W, Huang M, Chen YZ. Drug bioactivation, covalent binding to target proteins and toxicity relevance. Drug Metab Rev 2005;37:41-213. [PMID: 15747500 DOI: 10.1081/dmr-200028812] [Cited by in Crossref: 168] [Cited by in F6Publishing: 33] [Article Influence: 9.9] [Reference Citation Analysis]
8 Tesfa E, Siefu D, Belayneh Y, Mekonnen Z. Liver enzyme elevation in patients taking HAART compared with treatment naïve controls at Debre Berhan Referral Hospital: a comparative cross-sectional study, Northeast Ethiopia. BMC Res Notes 2019;12:714. [PMID: 31666123 DOI: 10.1186/s13104-019-4748-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
9 Giordano CM, Zervos XB. Clinical Manifestations and Treatment of Drug-induced Hepatotoxicity. Clinics in Liver Disease 2013;17:565-73. [DOI: 10.1016/j.cld.2013.07.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
10 Nam HS, Hwang KS, Jeong YM, Ryu JI, Choi TY, Bae MA, Son WC, You KH, Son HY, Kim CH. Expression of miRNA-122 Induced by Liver Toxicants in Zebrafish. Biomed Res Int 2016;2016:1473578. [PMID: 27563662 DOI: 10.1155/2016/1473578] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
11 Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov. 2005;4:489-499. [PMID: 15931258 DOI: 10.1038/nrd1750] [Cited by in Crossref: 738] [Cited by in F6Publishing: 621] [Article Influence: 43.4] [Reference Citation Analysis]
12 Liu P, Jin X, Lv H, Li J, Xu W, Qian H, Yin Z. Icaritin ameliorates carbon tetrachloride-induced acute liver injury mainly because of the antioxidative function through estrogen-like effects. In Vitro Cell Dev Biol -Animal 2014;50:899-908. [DOI: 10.1007/s11626-014-9792-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
13 Giordano C, Rivas J, Zervos X. An Update on Treatment of Drug-Induced Liver Injury. J Clin Transl Hepatol 2014;2:74-9. [PMID: 26356645 DOI: 10.14218/JCTH.2014.00005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
14 Sahin M, Cam H, Olgar S, Tunc SE, Arslan C, Uz E, Yilmaz HR. Protective role of erdosteine on vancomycin-induced oxidative stress in rat liver. Mol Cell Biochem 2006;291:155-60. [DOI: 10.1007/s11010-006-9209-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
15 Sayeed S, Imam SS, Najmi AK, Aqil M, Akhtar M. Nonionic surfactant based thymoquinone loaded nanoproniosomal formulation: in vitro physicochemical evaluation and in vivo hepatoprotective efficacy. Drug Dev Ind Pharm 2017;43:1413-20. [PMID: 28402205 DOI: 10.1080/03639045.2017.1318903] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
16 Iloro I, Gonzalez E, Gutierrez-de Juan V, Mato JM, Falcon-perez JM, Elortza F. Non-invasive detection of drug toxicity in rats by solid-phase extraction and MALDI-TOF analysis of urine samples. Anal Bioanal Chem 2013;405:2311-20. [DOI: 10.1007/s00216-012-6644-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
17 Andrade RJ, Lucena MI. Drug Induced Liver Disease: Mechanisms and Diagnosis. In: Mcdonald JW, Burroughs AK, Feagan BG, Fennerty MB, editors. Evidence‐Based Gastroenterology and Hepatology. Wiley; 2010. pp. 771-86. [DOI: 10.1002/9781444314403.ch47] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Zhang Y, Cai Y, Zhang SR, Li CY, Jiang LL, Wei P, He MF. Mechanism of hepatotoxicity of first-line tyrosine kinase inhibitors: Gefitinib and afatinib. Toxicol Lett 2021;343:1-10. [PMID: 33571620 DOI: 10.1016/j.toxlet.2021.02.003] [Reference Citation Analysis]
19 O’brien PJ, Irwin W, Diaz D, Howard-cofield E, Krejsa CM, Slaughter MR, Gao B, Kaludercic N, Angeline A, Bernardi P, Brain P, Hougham C. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch Toxicol 2006;80:580-604. [DOI: 10.1007/s00204-006-0091-3] [Cited by in Crossref: 450] [Cited by in F6Publishing: 385] [Article Influence: 28.1] [Reference Citation Analysis]
20 Csermely P, Korcsmáros T, Kiss HJ, London G, Nussinov R. Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review. Pharmacol Ther 2013;138:333-408. [PMID: 23384594 DOI: 10.1016/j.pharmthera.2013.01.016] [Cited by in Crossref: 544] [Cited by in F6Publishing: 395] [Article Influence: 60.4] [Reference Citation Analysis]
21 Corsini A, Bortolini M. Drug-induced liver injury: the role of drug metabolism and transport. J Clin Pharmacol. 2013;53:463-474. [PMID: 23436293 DOI: 10.1002/jcph.23] [Cited by in Crossref: 84] [Cited by in F6Publishing: 75] [Article Influence: 9.3] [Reference Citation Analysis]
22 Miller TJ, Knapton A, Adeyemo O, Noory L, Weaver J, Hanig JP. Cytochrome c: a non-invasive biomarker of drug-induced liver injury. J Appl Toxicol 2008;28:815-28. [PMID: 18418843 DOI: 10.1002/jat.1347] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
23 Chang CW, Beland FA, Hines WM, Fuscoe JC, Han T, Chen JJ. Identification and categorization of liver toxicity markers induced by a related pair of drugs. Int J Mol Sci 2011;12:4609-24. [PMID: 21845099 DOI: 10.3390/ijms12074609] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
24 Wang L, Prasad B, Salphati L, Chu X, Gupta A, Hop CE, Evers R, Unadkat JD. Interspecies variability in expression of hepatobiliary transporters across human, dog, monkey, and rat as determined by quantitative proteomics. Drug Metab Dispos 2015;43:367-74. [PMID: 25534768 DOI: 10.1124/dmd.114.061580] [Cited by in Crossref: 108] [Cited by in F6Publishing: 99] [Article Influence: 13.5] [Reference Citation Analysis]
25 Paz MFCJ, de Alencar MVOB, de Lima RMP, Sobral ALP, do Nascimento GTM, Dos Reis CA, Coêlho MDPSS, do Nascimento MLLB, Gomes Júnior AL, Machado KDC, de Menezes APM, de Lima RMT, de Oliveira Filho JWG, Dias ACS, Dos Reis AC, da Mata AMOF, Machado SA, Sousa CDC, da Silva FCC, Islam MT, de Castro E Sousa JM, Melo Cavalcante AAC. Pharmacological Effects and Toxicogenetic Impacts of Omeprazole: Genomic Instability and Cancer. Oxid Med Cell Longev 2020;2020:3457890. [PMID: 32308801 DOI: 10.1155/2020/3457890] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Lucena MI, Cohen H, Hernández N, Bessone F, Dacoll C, Stephens C, Borraz Y, Ulzurrun E, Bruguera M, Andrade RJ. Hepatotoxicidad, un problema global con especificidades locales: hacia la creación de una Red Hispano Latinoamericana de Hepatotoxicidad. Gastroenterología y Hepatología 2011;34:361-8. [DOI: 10.1016/j.gastrohep.2011.01.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
27 Zilfou JT, Lowe SW. Tumor suppressive functions of p53. Cold Spring Harb Perspect Biol. 2009;1:a001883. [PMID: 20066118 DOI: 10.1101/cshperspect.a001883] [Cited by in Crossref: 309] [Cited by in F6Publishing: 297] [Article Influence: 25.8] [Reference Citation Analysis]
28 Moreira PR, Maioli MA, Medeiros HC, Guelfi M, Pereira FT, Mingatto FE. Protective effect of bixin on carbon tetrachloride-induced hepatotoxicity in rats. Biol Res 2014;47:49. [PMID: 25299839 DOI: 10.1186/0717-6287-47-49] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
29 Lewis JH. Drug-Induced Liver Injury Throughout the Drug Development Life Cycle: Where We Have Been, Where We are Now, and Where We are Headed. Perspectives of a Clinical Hepatologist. Pharm Med 2013;27:165-91. [DOI: 10.1007/s40290-013-0015-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
30 Thibault A, Brissette S, Jutras-Aswad D. Systematic review of the pharmacological treatment of alcohol use disorders in individuals infected with hepatitis C. Addict Sci Clin Pract 2015;10:6. [PMID: 25928362 DOI: 10.1186/s13722-015-0029-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
31 Björnsson E. Hepatotoxicity associated with antiepileptic drugs. Acta Neurologica Scandinavica 2008;118:281-90. [DOI: 10.1111/j.1600-0404.2008.01009.x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 70] [Article Influence: 6.8] [Reference Citation Analysis]
32 Gunawan B, Kaplowitz N. Clinical Perspectives on Xenobiotic‐Induced Hepatotoxicity. Drug Metabolism Reviews 2004;36:301-12. [DOI: 10.1081/dmr-120034148] [Cited by in Crossref: 69] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
33 Bionda N, Stawikowski M, Stawikowska R, Cudic M, López-Vallejo F, Treitl D, Medina-Franco J, Cudic P. Effects of cyclic lipodepsipeptide structural modulation on stability, antibacterial activity, and human cell toxicity. ChemMedChem 2012;7:871-82. [PMID: 22392790 DOI: 10.1002/cmdc.201200016] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
34 Liu F, Cai P, Metushi I, Li J, Nakayawa T, Vega L, Uetrecht J. Exploring an animal model of amodiaquine-induced liver injury in rats and mice. J Immunotoxicol 2016;13:694-712. [PMID: 27416278 DOI: 10.3109/1547691X.2016.1166167] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Vinothkumar G, Venkataraman P, Vinodhini V, Lavanya R, Sathishkumar D. Effect of Coccinia indica leaf extract on angiotensin converting enzyme (ACE) inhibitor induced hepatotoxicity in wistar albino rats. Clinical Nutrition Experimental 2019;24:24-33. [DOI: 10.1016/j.yclnex.2019.01.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Gonzalez E, van Liempd S, Conde-Vancells J, Gutierrez-de Juan V, Perez-Cormenzana M, Mayo R, Berisa A, Alonso C, Marquez CA, Barr J, Lu SC, Mato JM, Falcon-Perez JM. Serum UPLC-MS/MS metabolic profiling in an experimental model for acute-liver injury reveals potential biomarkers for hepatotoxicity. Metabolomics 2012;8:997-1011. [PMID: 23139648 DOI: 10.1007/s11306-011-0329-9] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 4.7] [Reference Citation Analysis]
37 Amin ZA, Bilgen M, Alshawsh MA, Ali HM, Hadi AH, Abdulla MA. Protective Role of Phyllanthus niruri Extract against Thioacetamide-Induced Liver Cirrhosis in Rat Model. Evid Based Complement Alternat Med 2012;2012:241583. [PMID: 22649471 DOI: 10.1155/2012/241583] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
38 Bizerra PFV, Guimarães ARJS, Miranda CA, Constantin RP, Utsunomiya KS, Gilglioni EH, Constantin J, Ishii-Iwamoto EL, Maioli MA, Mingatto FE. Enhanced cytotoxicity of imidacloprid by biotransformation in isolated hepatocytes and perfused rat liver. Pestic Biochem Physiol 2020;164:183-90. [PMID: 32284125 DOI: 10.1016/j.pestbp.2020.01.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Holt M, Ju C. Drug-Induced Liver Injury. In: Uetrecht J, editor. Adverse Drug Reactions. Berlin: Springer Berlin Heidelberg; 2010. pp. 3-27. [DOI: 10.1007/978-3-642-00663-0_1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
40 Kilany OE, El-Beltagy MA, El-Sherbeeny NA. Tribulus terrestris ameliorates carbon tetrachloride-induced hepatotoxicity in male rats through suppression of oxidative stress and inflammation. Environ Sci Pollut Res Int 2020;27:24967-81. [PMID: 32342415 DOI: 10.1007/s11356-020-08826-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Singh D, Cho WC, Upadhyay G. Drug-Induced Liver Toxicity and Prevention by Herbal Antioxidants: An Overview. Front Physiol 2015;6:363. [PMID: 26858648 DOI: 10.3389/fphys.2015.00363] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 8.2] [Reference Citation Analysis]
42 Sayed MM, El-kordy EA. The protective effect of curcumin on paracetamol-induced liver damage in adult male rabbits: biochemical and histological studies. The Egyptian Journal of Histology 2014;37:629-39. [DOI: 10.1097/01.ehx.0000455822.82783.4b] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
43 Eraky SM, El-Mesery M, El-Karef A, Eissa LA, El-Gayar AM. Silymarin and caffeine combination ameliorates experimentally-induced hepatic fibrosis through down-regulation of LPAR1 expression. Biomed Pharmacother 2018;101:49-57. [PMID: 29477472 DOI: 10.1016/j.biopha.2018.02.064] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
44 Lo Re V, Haynes K, Forde KA, Goldberg DS, Lewis JD, Carbonari DM, Leidl KB, Reddy KR, Nezamzadeh MS, Roy J. Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy’s Law and a New Prognostic Model. Clin Gastroenterol Hepatol. 2015;13:2360-2368. [PMID: 26122767 DOI: 10.1016/j.cgh.2015.06.020] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 5.1] [Reference Citation Analysis]
45 Mitchell SJ, Hilmer SN. Drug-induced liver injury in older adults. Ther Adv Drug Saf 2010;1:65-77. [PMID: 25083196 DOI: 10.1177/2042098610386281] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
46 Susukida T, Sekine S, Nozaki M, Tokizono M, Oizumi K, Horie T, Ito K. Establishment of a Drug-Induced, Bile Acid–Dependent Hepatotoxicity Model Using HepaRG Cells. Journal of Pharmaceutical Sciences 2016;105:1550-60. [DOI: 10.1016/j.xphs.2016.01.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
47 Marion TL, Leslie EM, Brouwer KLR. Use of Sandwich-Cultured Hepatocytes To Evaluate Impaired Bile Acid Transport as a Mechanism of Drug-Induced Hepatotoxicity. Mol Pharmaceutics 2007;4:911-8. [DOI: 10.1021/mp0700357] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 4.7] [Reference Citation Analysis]
48 Vatsalya V, Pandey A, Schwandt ML, Cave MC, Barve SS, Ramchandani VA, McClain CJ. Safety Assessment of Liver Injury with Quetiapine Fumarate XR Management in Very Heavy Drinking Alcohol-Dependent Patients. Clin Drug Investig 2016;36:935-44. [PMID: 27503091 DOI: 10.1007/s40261-016-0439-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
49 Kawase A, Hashimoto R, Shibata M, Shimada H, Iwaki M. Involvement of Reactive Metabolites of Diclofenac in Cytotoxicity in Sandwich-Cultured Rat Hepatocytes. Int J Toxicol 2017;36:260-7. [DOI: 10.1177/1091581817700584] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
50 Gabriel A, van den Ingh TS, Clercx C, Peeters D. Suspected drug-induced destructive cholangitis in a young dog. J Small Anim Pract 2006;47:344-8. [PMID: 16761987 DOI: 10.1111/j.1748-5827.2006.00155.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
51 Ogimura E, Sekine S, Horie T. Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes. Biochem Biophys Res Commun. 2011;416:313-317. [PMID: 22108051 DOI: 10.1016/j.bbrc.2011.11.032] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
52 Soriano V, Puoti M, Garcia-Gascó P, Rockstroh JK, Benhamou Y, Barreiro P, McGovern B. Antiretroviral drugs and liver injury. AIDS 2008;22:1-13. [PMID: 18090386 DOI: 10.1097/QAD.0b013e3282f0e2fd] [Cited by in Crossref: 121] [Cited by in F6Publishing: 45] [Article Influence: 8.6] [Reference Citation Analysis]
53 Lesiński W, Mnich K, Golińska AK, Rudnicki WR. Integration of human cell lines gene expression and chemical properties of drugs for Drug Induced Liver Injury prediction. Biol Direct 2021;16:2. [PMID: 33422118 DOI: 10.1186/s13062-020-00286-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
54 Marion TL, Perry CH, St Claire RL 3rd, Brouwer KL. Endogenous bile acid disposition in rat and human sandwich-cultured hepatocytes. Toxicol Appl Pharmacol 2012;261:1-9. [PMID: 22342602 DOI: 10.1016/j.taap.2012.02.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
55 Takai S, Oda S, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Establishment of a mouse model for amiodarone-induced liver injury and analyses of its hepatotoxic mechanism: Mechanism of amiodarone-induced liver injury. J Appl Toxicol 2016;36:35-47. [DOI: 10.1002/jat.3141] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
56 Demirbas S, Cakir E, Akgul EO, Seyrek M, Cayci T, Kurt YG, Uysal B, Aydin I, Kurt B, Yaman H, Erbil MK. Elevated serum neopterin levels in acetaminophen-induced liver injury. Environmental Toxicology and Pharmacology 2011;31:165-70. [DOI: 10.1016/j.etap.2010.10.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
57 Anene-nzelu C, Wang Y, Yu H, Liang LH. LIVER TISSUE MODEL FOR DRUG TOXICITY SCREENING. J Mech Med Biol 2011;11:369-90. [DOI: 10.1142/s0219519411004083] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
58 Cosgrove BD, Alexopoulos LG, Saez-Rodriguez J, Griffith LG, Lauffenburger DA. A multipathway phosphoproteomic signaling network model of idiosyncratic drug- and inflammatory cytokine-induced toxicity in human hepatocytes. Annu Int Conf IEEE Eng Med Biol Soc 2009;2009:5452-5. [PMID: 19964679 DOI: 10.1109/IEMBS.2009.5334019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
59 Montanari F, Pinto M, Khunweeraphong N, Wlcek K, Sohail MI, Noeske T, Boyer S, Chiba P, Stieger B, Kuchler K, Ecker GF. Flagging Drugs That Inhibit the Bile Salt Export Pump. Mol Pharm 2016;13:163-71. [PMID: 26642869 DOI: 10.1021/acs.molpharmaceut.5b00594] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
60 Watkins PB, Dube LM, Walton-Bowen K, Cameron CM, Kasten LE. Clinical pattern of zileuton-associated liver injury: results of a 12-month study in patients with chronic asthma. Drug Saf 2007;30:805-15. [PMID: 17722971 DOI: 10.2165/00002018-200730090-00006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
61 Martin-Murphy BV, Holt MP, Ju C. The role of damage associated molecular pattern molecules in acetaminophen-induced liver injury in mice. Toxicol Lett. 2010;192:387-394. [PMID: 19931603 DOI: 10.1016/j.toxlet.2009.11.016] [Cited by in Crossref: 157] [Cited by in F6Publishing: 146] [Article Influence: 12.1] [Reference Citation Analysis]
62 Baker JD. Tradition and toxicity: Evidential cultures in the kava safety debate. Soc Stud Sci 2011;41:361-84. [DOI: 10.1177/0306312710395341] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
63 Zhou S. Separation and detection methods for covalent drug–protein adducts. Journal of Chromatography B 2003;797:63-90. [DOI: 10.1016/s1570-0232(03)00399-4] [Cited by in Crossref: 43] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
64 Kawase A, Kaneto A, Ishibashi M, Kobayashi A, Shimada H, Iwaki M. Involvement of diclofenac acyl-β-d-glucuronide in diclofenac-induced cytotoxicity in glutathione-depleted isolated murine hepatocytes co-cultured with peritoneal macrophages. Toxicol Mech Methods 2019;29:203-10. [PMID: 30489186 DOI: 10.1080/15376516.2018.1544384] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
65 Chojkier M. Troglitazone and liver injury: In search of answers. Hepatology 2005;41:237-46. [DOI: 10.1002/hep.20567] [Cited by in Crossref: 84] [Cited by in F6Publishing: 70] [Article Influence: 4.9] [Reference Citation Analysis]
66 Boelsterli UA. Mechanisms of NSAID-induced hepatotoxicity: focus on nimesulide. Drug Saf. 2002;25:633-648. [PMID: 12137558 DOI: 10.2165/00002018-200225090-00003] [Cited by in Crossref: 107] [Cited by in F6Publishing: 92] [Article Influence: 5.4] [Reference Citation Analysis]
67 Kaplowitz N. Drug-induced liver injury. Clin Infect Dis. 2004;38 Suppl 2:S44-S48. [PMID: 14986274 DOI: 10.1086/381446] [Cited by in Crossref: 232] [Cited by in F6Publishing: 185] [Article Influence: 12.9] [Reference Citation Analysis]
68 McGovern BH, Birch C, Zaman MT, Bica I, Stone D, Quirk JR, Davis B, Zachary K, Basgoz N, Graeme-Cook F, Gandhi RT. Managing symptomatic drug-induced liver injury in HIV-hepatitis C virus-coinfected patients: a role for interferon. Clin Infect Dis 2007;45:1386-92. [PMID: 17968840 DOI: 10.1086/522174] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
69 Björnsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology. 2005;42:481-489. [PMID: 16025496 DOI: 10.1002/hep.20800] [Cited by in Crossref: 393] [Cited by in F6Publishing: 345] [Article Influence: 23.1] [Reference Citation Analysis]
70 Mcburney RN, Hines WM, Von Tungeln LS, Schnackenberg LK, Beger RD, Moland CL, Tao Han, Fuscoe JC, Chang C, Chen JJ, Zhenqiang Su, Fan X, Weida Tong, Booth SA, Balasubramanian R, Courchesne PL, Campbell JM, Graber A, Yu Guo, Juhasz PJ, Li TY, Lynch MD, Morel NM, Plasterer TN, Takach EJ, Chenhui Zeng, Beland FA. The Liver Toxicity Biomarker Study: Phase I Design and Preliminary Results. Toxicol Pathol 2009;37:52-64. [DOI: 10.1177/0192623308329287] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
71 Llanos L, Moreu R, Ortin T, Peiró AM, Pascual S, Bellot P, Barquero C, Francés R, Such J, Pérez-mateo M, Horga JF, Zapater P. The existence of a relationship between increased serum alanine aminotransferase levels detected in premarketing clinical trials and postmarketing published hepatotoxicity case reports: HEPATOTOXICITY, ALT LEVELS AND DILI CASE REPORTS. Alimentary Pharmacology & Therapeutics 2010;31:1337-45. [DOI: 10.1111/j.1365-2036.2010.04298.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
72 Srivastava A, Maggs JL, Antoine DJ, Williams DP, Smith DA, Park BK. Role of reactive metabolites in drug-induced hepatotoxicity. Handb Exp Pharmacol. 2010;196:165-194. [PMID: 20020263 DOI: 10.1007/978-3-642-00663-0_7] [Cited by in Crossref: 87] [Cited by in F6Publishing: 75] [Article Influence: 7.3] [Reference Citation Analysis]
73 Isabel Lucena M, García-cortés M, Cueto R, Lopez-duran J, Andrade RJ. Assessment of drug-induced liver injury in clinical practice. Fundam Clin Pharmacol 2008;22:141-58. [DOI: 10.1111/j.1472-8206.2008.00566.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
74 Francis GS, Grumser Y, Alteri E, Micaleff A, O'Brien F, Alsop J, Stam Moraga M, Kaplowitz N. Hepatic reactions during treatment of multiple sclerosis with interferon-beta-1a: incidence and clinical significance. Drug Saf 2003;26:815-27. [PMID: 12908850 DOI: 10.2165/00002018-200326110-00006] [Cited by in Crossref: 75] [Cited by in F6Publishing: 63] [Article Influence: 4.2] [Reference Citation Analysis]
75 Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl. 2004;10:1018-1023. [PMID: 15390328 DOI: 10.1002/lt.20204] [Cited by in Crossref: 311] [Cited by in F6Publishing: 269] [Article Influence: 17.3] [Reference Citation Analysis]
76 Deng X, Luyendyk JP, Ganey PE, Roth RA. Inflammatory stress and idiosyncratic hepatotoxicity: hints from animal models. Pharmacol Rev 2009;61:262-82. [PMID: 19805476 DOI: 10.1124/pr.109.001727] [Cited by in Crossref: 94] [Cited by in F6Publishing: 80] [Article Influence: 7.8] [Reference Citation Analysis]
77 Kim JK, Eun JW, Bae HJ, Shen Q, Park SJ, Kim HS, Park S, Ahn YM, Park WS, Lee JY, Nam SW. Characteristic molecular signatures of early exposure to volatile organic compounds in rat liver. Biomarkers 2013;18:706-15. [PMID: 24144218 DOI: 10.3109/1354750X.2013.847121] [Reference Citation Analysis]
78 Felser A, Lindinger PW, Schnell D, Kratschmar DV, Odermatt A, Mies S, Jenö P, Krähenbühl S. Hepatocellular toxicity of benzbromarone: effects on mitochondrial function and structure. Toxicology 2014;324:136-46. [PMID: 25108121 DOI: 10.1016/j.tox.2014.08.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
79 Jamshidzadeh A, Heidari R, Abazari F, Ramezani M, Khodaei F, Ommati MM, Ayarzadeh M, Firuzi R, Saeedi A, Azarpira N, Najibi A. Antimalarial Drugs-Induced Hepatic Injury in Rats and the Protective Role of Carnosine. Pharm Sci 2016;22:170-80. [DOI: 10.15171/ps.2016.27] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
80 Elefsiniotis IS, Pantazis KD, Ilias A, Pallis L, Mariolis A, Glynou I, Kada H, Moulakakis A. Tamoxifen induced hepatotoxicity in breast cancer patients with pre-existing liver steatosis: the role of glucose intolerance. European Journal of Gastroenterology & Hepatology 2004;16:593-8. [DOI: 10.1097/00042737-200406000-00013] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 2.7] [Reference Citation Analysis]
81 Fernando Sierra A, Diana Torres P. A concise and structured review of drug-induced toxic hepatic disease. Annals of Hepatology 2004;3:18-25. [DOI: 10.1016/s1665-2681(19)32120-9] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
82 Susukida T, Sekine S, Ogimura E, Aoki S, Oizumi K, Horie T, Ito K. Basal efflux of bile acids contributes to drug-induced bile acid-dependent hepatocyte toxicity in rat sandwich-cultured hepatocytes. Toxicology in Vitro 2015;29:1454-63. [DOI: 10.1016/j.tiv.2015.06.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
83 Schnackenberg LK, Beger RD. The role of metabolic biomarkers in drug toxicity studies. Toxicol Mech Methods 2008;18:301-11. [PMID: 20020895 DOI: 10.1080/15376510701623193] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
84 Lo Re V, Haynes K, Goldberg D, Forde KA, Carbonari DM, Leidl KB, Hennessy S, Reddy KR, Pawloski PA, Daniel GW. Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration’s Mini-Sentinel Distributed Database. Pharmacoepidemiol Drug Saf. 2013;22:861-872. [PMID: 23801638 DOI: 10.1002/pds.3470] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
85 McMillin M, Grant S, Frampton G, Petrescu AD, Williams E, Jefferson B, Thomas A, Brahmaroutu A, DeMorrow S. Elevated circulating TGFβ1 during acute liver failure activates TGFβR2 on cortical neurons and exacerbates neuroinflammation and hepatic encephalopathy in mice. J Neuroinflammation 2019;16:69. [PMID: 30940161 DOI: 10.1186/s12974-019-1455-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
86 Akindele AJ, Ezenwanebe KO, Anunobi CC, Adeyemi OO. Hepatoprotective and in vivo antioxidant effects of Byrsocarpus coccineus Schum. and Thonn. (Connaraceae). Journal of Ethnopharmacology 2010;129:46-52. [DOI: 10.1016/j.jep.2010.02.024] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
87 Babai S, Auclert L, Le-Louët H. Safety data and withdrawal of hepatotoxic drugs. Therapie 2018:S0040-5957(18)30036-2. [PMID: 29609830 DOI: 10.1016/j.therap.2018.02.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
88 Weber S, Benesic A, Neumann J, Gerbes AL. Liver Injury Associated with Metamizole Exposure: Features of an Underestimated Adverse Event. Drug Saf 2021;44:669-80. [PMID: 33638811 DOI: 10.1007/s40264-021-01049-z] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
89 Liu ZX, Kaplowitz N. Immune-mediated drug-induced liver disease. Clin Liver Dis. 2002;6:755-774. [PMID: 12362579 DOI: 10.1016/s1089-3261(02)00025-9] [Cited by in Crossref: 140] [Cited by in F6Publishing: 35] [Article Influence: 7.4] [Reference Citation Analysis]
90 Chen S, Melchior WB Jr, Guo L. Endoplasmic reticulum stress in drug- and environmental toxicant-induced liver toxicity. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2014;32:83-104. [PMID: 24598041 DOI: 10.1080/10590501.2014.881648] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
91 Russmann S, Kullak-Ublick GA, Grattagliano I. Current concepts of mechanisms in drug-induced hepatotoxicity. Curr Med Chem 2009;16:3041-53. [PMID: 19689281 DOI: 10.2174/092986709788803097] [Cited by in Crossref: 231] [Cited by in F6Publishing: 202] [Article Influence: 17.8] [Reference Citation Analysis]
92 Jung KH, Kim JK, Kim MG, Noh JH, Eun JW, Bae HJ, Chang YG, Shen Q, Park WS, Lee JY, Nam SW. Characteristic Molecular Signature for Early Detection and Prediction of Persistent Organic Pollutants in Rat Liver. Environ Sci Technol 2012;46:12882-9. [DOI: 10.1021/es302480v] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
93 Arora N, Goldhaber SZ. Anticoagulants and transaminase elevation. Circulation 2006;113:e698-702. [PMID: 16618822 DOI: 10.1161/CIRCULATIONAHA.105.603100] [Cited by in Crossref: 23] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
94 Hughes TB, Flynn N, Dang NL, Swamidass SJ. Modeling the Bioactivation and Subsequent Reactivity of Drugs. Chem Res Toxicol 2021;34:584-600. [PMID: 33496184 DOI: 10.1021/acs.chemrestox.0c00417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
95 Shi Q, Yang X, Greenhaw JJ, Salminen AT, Russotti GM, Salminen WF. Drug-Induced Liver Injury in Children: Clinical Observations, Animal Models, and Regulatory Status. Int J Toxicol 2017;36:365-79. [PMID: 28820004 DOI: 10.1177/1091581817721675] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
96 Guo X, Li W, An R, Huang M, Yu Z. Composite ammonium glycyrrhizin has hepatoprotective effects in chicken hepatocytes with lipopolysaccharide/enrofloxacin-induced injury. Exp Ther Med 2020;20:52. [PMID: 32952642 DOI: 10.3892/etm.2020.9180] [Reference Citation Analysis]
97 Redondo Cerezo E, Espinosa Aguilar MD, Nogueras López F, Martín-Vivaldi Martínez R. [Zolmitriptan-induced hepatotoxicity]. Gastroenterol Hepatol 2003;26:664. [PMID: 14670242 DOI: 10.1016/s0210-5705(03)70428-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
98 Nam SW, Baek JT, Lee DS, Kang SB, Ahn BM, Chung KW. A case of acute cholestatic hepatitis associated with the seeds of Psoralea corylifolia (Boh-Gol-Zhee). Clin Toxicol (Phila). 2005;43:589-591. [PMID: 16255343 DOI: 10.1081/clt-200068863] [Cited by in Crossref: 52] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
99 Petronijevic M, Ilic K, Suzuki A. Drug induced hepatotoxicity: data from the Serbian pharmacovigilance database: REPORTING OF HEPATOTOXICITY IN SERBIA. Pharmacoepidem Drug Safe 2011;20:416-23. [DOI: 10.1002/pds.2115] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
100 Ali I, Welch MA, Lu Y, Swaan PW, Brouwer KLR. Identification of novel MRP3 inhibitors based on computational models and validation using an in vitro membrane vesicle assay. Eur J Pharm Sci 2017;103:52-9. [PMID: 28238947 DOI: 10.1016/j.ejps.2017.02.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
101 Andrade RJ, Camargo R, Lucena MI, González-Grande R. Causality assessment in drug-induced hepatotoxicity. Expert Opin Drug Saf. 2004;3:329-344. [PMID: 15268650 DOI: 10.1517/14740338.3.4.329] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 3.2] [Reference Citation Analysis]
102 Florczyk M, Brzuzan P, Krom J, Woźny M, Łakomiak A. miR-122-5p as a plasma biomarker of liver injury in fish exposed to microcystin-LR. J Fish Dis 2016;39:741-51. [PMID: 26345281 DOI: 10.1111/jfd.12406] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
103 Grieco A, Miele L, Giorgi A, Civello IM, Gasbarrini G. Acute Cholestatic Hepatitis Associated with Celecoxib. Ann Pharmacother 2002;36:1887-9. [DOI: 10.1345/aph.1c110] [Cited by in Crossref: 25] [Cited by in F6Publishing: 6] [Article Influence: 4.2] [Reference Citation Analysis]
104 Dash A, Simmers MB, Deering TG, Berry DJ, Feaver RE, Hastings NE, Pruett TL, LeCluyse EL, Blackman BR, Wamhoff BR. Hemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitro. Am J Physiol Cell Physiol 2013;304:C1053-63. [PMID: 23485712 DOI: 10.1152/ajpcell.00331.2012] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 7.7] [Reference Citation Analysis]
105 Kaddah MMY, Billig S, Oehme R, Birkemeyer C. Bio-activation of simeprevir in liver microsomes and characterization of its glutathione conjugates by liquid chromatography coupled to ultrahigh-resolution quadrupole time-of-flight mass spectrometry. J Chromatogr A 2021;1645:462095. [PMID: 33857675 DOI: 10.1016/j.chroma.2021.462095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Cosgrove BD, King BM, Hasan MA, Alexopoulos LG, Farazi PA, Hendriks BS, Griffith LG, Sorger PK, Tidor B, Xu JJ, Lauffenburger DA. Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity. Toxicol Appl Pharmacol 2009;237:317-30. [PMID: 19362101 DOI: 10.1016/j.taap.2009.04.002] [Cited by in Crossref: 106] [Cited by in F6Publishing: 94] [Article Influence: 8.2] [Reference Citation Analysis]
107 Perry CH, Smith WR, St. Claire RL, Brouwer KR. Automated Applications of Sandwich-Cultured Hepatocytes in the Evaluation of Hepatic Drug Transport. J Biomol Screen 2011;16:427-35. [DOI: 10.1177/1087057111400192] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
108 Ansede JH, Smith WR, Perry CH, St Claire RL, Brouwer KR. An in vitro assay to assess transporter-based cholestatic hepatotoxicity using sandwich-cultured rat hepatocytes. Drug Metab Dispos. 2010;38:276-280. [PMID: 19910518 DOI: 10.1124/dmd.109.028407] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 5.0] [Reference Citation Analysis]
109 Tuschl G, Lauer B, Mueller SO. Primary hepatocytes as a model to analyze species-specific toxicity and drug metabolism. Expert Opinion on Drug Metabolism & Toxicology 2008;4:855-70. [DOI: 10.1517/17425255.4.7.855] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
110 Martin-Murphy BV, Kominsky DJ, Orlicky DJ, Donohue TM Jr, Ju C. Increased susceptibility of natural killer T-cell-deficient mice to acetaminophen-induced liver injury. Hepatology. 2013;57:1575-1584. [PMID: 23150232 DOI: 10.1002/hep.26134] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 4.9] [Reference Citation Analysis]
111 Andrade RJ, Robles M, Fernández-Castañer A, López-Ortega S, López-Vega MC, Lucena MI. Assessment of drug-induced hepatotoxicity in clinical practice: A challenge for gastroenterologists. World J Gastroenterol 2007; 13(3): 329-340 [PMID: 17230599 DOI: 10.3748/wjg.v13.i3.329] [Cited by in CrossRef: 87] [Cited by in F6Publishing: 67] [Article Influence: 5.8] [Reference Citation Analysis]
112 Kim K, Chung MW, Um SY, Oh JS, Kim SH, Na MA, Oh HY, Cho W, Choi KH. Metabolomics and biomarker discovery: NMR spectral data of urine and hepatotoxicity by carbon tetrachloride, acetaminophen, and d-galactosamine in rats. Metabolomics 2008;4:377-92. [DOI: 10.1007/s11306-008-0131-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
113 Chen S, Melchior WB Jr, Wu Y, Guo L. Autophagy in drug-induced liver toxicity. J Food Drug Anal 2014;22:161-8. [PMID: 29249890 DOI: 10.1016/j.jfda.2014.03.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
114 Andrade RJ, López-Ortega S, López-Vega MC, Robles M, Cueto I, Lucena MI. Idiosyncratic drug hepatotoxicity: a 2008 update. Expert Rev Clin Pharmacol 2008;1:261-76. [PMID: 24422651 DOI: 10.1586/17512433.1.2.261] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
115 Chen M, Vijay V, Shi Q, Liu Z, Fang H, Tong W. FDA-approved drug labeling for the study of drug-induced liver injury. Drug Discov Today. 2011;16:697-703. [PMID: 21624500 DOI: 10.1016/j.drudis.2011.05.007] [Cited by in Crossref: 245] [Cited by in F6Publishing: 208] [Article Influence: 22.3] [Reference Citation Analysis]
116 Gerloff T, Geier A, Roots I, Meier PJ, Gartung C. Functional analysis of the rat bile salt export pump gene promoter. Eur J Biochem 2002;269:3495-503. [PMID: 12135489 DOI: 10.1046/j.1432-1033.2002.03030.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
117 Tailor A, Faulkner L, Naisbitt D, Park B. The chemical, genetic and immunological basis of idiosyncratic drug–induced liver injury. Hum Exp Toxicol 2015;34:1310-7. [DOI: 10.1177/0960327115606529] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
118 Zakaria ZA, Rofiee MS, Somchit MN, Zuraini A, Sulaiman MR, Teh LK, Salleh MZ, Long K. Hepatoprotective activity of dried- and fermented-processed virgin coconut oil. Evid Based Complement Alternat Med. 2011;2011:142739. [PMID: 21318140 DOI: 10.1155/2011/142739] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
119 Hadi M, Westra IM, Starokozhko V, Dragovic S, Merema MT, Groothuis GM. Human precision-cut liver slices as an ex vivo model to study idiosyncratic drug-induced liver injury. Chem Res Toxicol. 2013;26:710-720. [PMID: 23565644 DOI: 10.1021/tx300519p] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
120 Puoti M, Nasta P, Gatti F, Matti A, Prestini K, Biasi L, Carosi G. HIV-related liver disease: ARV drugs, coinfection, and other risk factors. J Int Assoc Physicians AIDS Care (Chic) 2009;8:30-42. [PMID: 19211929 DOI: 10.1177/1545109708330906] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
121 Duarte-Rojo A, Heathcote EJ. Efficacy and safety of tenofovir disoproxil fumarate in patients with chronic hepatitis B. Therap Adv Gastroenterol 2010;3:107-19. [PMID: 21180595 DOI: 10.1177/1756283X09354562] [Cited by in Crossref: 36] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
122 Tolosa L, Pinto S, Donato MT, Lahoz A, Castell JV, O’connor JE, Gómez-lechón MJ. Development of a Multiparametric Cell-based Protocol to Screen and Classify the Hepatotoxicity Potential of Drugs. Toxicological Sciences 2012;127:187-98. [DOI: 10.1093/toxsci/kfs083] [Cited by in Crossref: 85] [Cited by in F6Publishing: 77] [Article Influence: 8.5] [Reference Citation Analysis]
123 Han D, Matsumaru K, Rettori D, Kaplowitz N. Usnic acid-induced necrosis of cultured mouse hepatocytes: inhibition of mitochondrial function and oxidative stress. Biochem Pharmacol 2004;67:439-51. [PMID: 15037196 DOI: 10.1016/j.bcp.2003.09.032] [Cited by in Crossref: 128] [Cited by in F6Publishing: 112] [Article Influence: 7.1] [Reference Citation Analysis]
124 Mohi-Ud-Din R, Mir RH, Sawhney G, Dar MA, Bhat ZA. Possible Pathways of Hepatotoxicity Caused by Chemical Agents. Curr Drug Metab 2019;20:867-79. [PMID: 31702487 DOI: 10.2174/1389200220666191105121653] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
125 Yu S, Jiang R, Mazzu YZ, Wei C, Sun Z, Zhang Y, Zhou L, Zhang Q. Epigallocatechin-3-gallate Prevents Triptolide-Induced Hepatic Injury by Restoring the Th17/T reg Balance in Mice. Am J Chin Med 2016;44:1221-36. [DOI: 10.1142/s0192415x16500683] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
126 Sun J, Slavov S, Schnackenberg LK, Ando Y, Greenhaw J, Yang X, Salminen W, Mendrick DL, Beger R. Identification of a metabolic biomarker panel in rats for prediction of acute and idiosyncratic hepatotoxicity. Comput Struct Biotechnol J 2014;10:78-89. [PMID: 25379137 DOI: 10.1016/j.csbj.2014.08.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
127 Bischoff K, Mukai M, Ramaiah SK. Liver Toxicity. Veterinary Toxicology. Elsevier; 2018. pp. 239-57. [DOI: 10.1016/b978-0-12-811410-0.00015-5] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
128 Hassan A, Hammad R, Cucco R, Niranjan S. Hydralazine-Induced Cholestatic Hepatitis. American Journal of Therapeutics 2009;16:371-3. [DOI: 10.1097/mjt.0b013e31817fde85] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
129 Xia YY, Hu DY, Liu FY, Wang XM, Yuan YL, Tu DH, Chen YX, Zhou L, Zhu LZ, Gao WW. Design of the anti-tuberculosis drugs induced adverse reactions in China National Tuberculosis Prevention and Control Scheme Study (ADACS). BMC Public Health. 2010;10:267. [PMID: 20492672 DOI: 10.1186/1471-2458-10-267] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
130 Beger RD, Sun J, Schnackenberg LK. Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity. Toxicology and Applied Pharmacology 2010;243:154-66. [DOI: 10.1016/j.taap.2009.11.019] [Cited by in Crossref: 166] [Cited by in F6Publishing: 150] [Article Influence: 13.8] [Reference Citation Analysis]
131 Oizumi K, Sekine S, Fukagai M, Susukida T, Ito K. Identification of Bile Acids Responsible for Inhibiting the Bile Salt Export Pump, Leading to Bile Acid Accumulation and Cell Toxicity in Rat Hepatocytes. Journal of Pharmaceutical Sciences 2017;106:2412-9. [DOI: 10.1016/j.xphs.2017.05.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
132 Hardman RC, Kullman SW, Hinton DE. Non invasive in vivo investigation of hepatobiliary structure and function in STII medaka (Oryzias latipes): methodology and applications. Comp Hepatol 2008;7:7. [PMID: 18838008 DOI: 10.1186/1476-5926-7-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
133 Lima IR, Silva IB, Lima RML, Silva TMS, Maia MBS, Leite SP. HEPATOPROTECTIVE EFFICACY OF METHANOLIC EXTRACT OF INDIGOFERA SUFFRUTICOSA (MILL) ON PARACETAMOL-INDUCED LIVER DAMAGE IN MICE. Arq Gastroenterol 2019;56:333-8. [PMID: 31721967 DOI: 10.1590/S0004-2803.201900000-62] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
134 Rizos CV, Elisaf MS, Mikhailidis DP, Liberopoulos EN. How safe is the use of thiazolidinediones in clinical practice? Expert Opin Drug Saf. 2009;8:15-32. [PMID: 19236215 DOI: 10.1517/14740330802597821] [Cited by in Crossref: 100] [Cited by in F6Publishing: 93] [Article Influence: 7.7] [Reference Citation Analysis]
135 Li L, Jiang W, Wang J. Clinical analysis of 275 cases of acute drug-induced liver disease. Front Med China 2007;1:58-61. [PMID: 24557619 DOI: 10.1007/s11684-007-0012-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
136 Zhang J, Jin Z, Hu X, Meng H, Li J, Zhang X, Liu H, Deng T, Yao S, Feng L. Efficient Two-Photon Fluorescent Probe for Glutathione S-Transferase Detection and Imaging in Drug-Induced Liver Injury Sample. Anal Chem 2017;89:8097-103. [DOI: 10.1021/acs.analchem.7b01659] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 8.4] [Reference Citation Analysis]
137 Jung KH, Kim JK, Noh JH, Eun JW, Bae HJ, Kim MG, Chang YG, Shen Q, Kim SJ, Kwon SH, Park WS, Lee JY, Nam SW. Characteristic molecular signature for the early detection and prediction of polycyclic aromatic hydrocarbons in rat liver. Toxicol Lett 2013;216:1-8. [PMID: 23147375 DOI: 10.1016/j.toxlet.2012.11.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
138 Zhou Y, Yang L, Liao Z, He X, Zhou Y, Guo H. Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21,789 patients. Eur J Gastroenterol Hepatol. 2013;25:825-829. [PMID: 23510965 DOI: 10.1097/meg.0b013e32835f6889] [Cited by in Crossref: 77] [Cited by in F6Publishing: 40] [Article Influence: 9.6] [Reference Citation Analysis]
139 Wichary H, Gasińska T. Methylprednisolone and Hepatotoxicity in Graves' Ophthalmopathy. Thyroid 2012;22:64-9. [DOI: 10.1089/thy.2010.0158] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
140 Ranadive I, Patel S, Mhaske A, Uggini GK, Desai I, Balakrishnan S. Evaluation of multikinase inhibitor LDN193189 induced hepatotoxicity in teleost fish Poecilia latipinna. Drug Chem Toxicol 2019;42:565-76. [PMID: 29498548 DOI: 10.1080/01480545.2018.1441865] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
141 Simeonova R, Vitcheva V, Kondeva-Burdina M, Krasteva I, Manov V, Mitcheva M. Hepatoprotective and antioxidant effects of saponarin, isolated from Gypsophila trichotoma Wend. on paracetamol-induced liver damage in rats. Biomed Res Int 2013;2013:757126. [PMID: 23878818 DOI: 10.1155/2013/757126] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
142 Korcsmaros T, Schneider MV, Superti-Furga G. Next generation of network medicine: interdisciplinary signaling approaches. Integr Biol (Camb) 2017;9:97-108. [PMID: 28106223 DOI: 10.1039/c6ib00215c] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
143 Mohamed WR, Kotb AS, Abd El-Raouf OM, Mohammad Fikry E. Apigenin alleviated acetaminophen-induced hepatotoxicity in low protein-fed rats: Targeting oxidative stress, STAT3, and apoptosis signals. J Biochem Mol Toxicol 2020;34:e22472. [PMID: 32048452 DOI: 10.1002/jbt.22472] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
144 Li H, Jia W. Cometabolism of microbes and host: implications for drug metabolism and drug-induced toxicity. Clin Pharmacol Ther. 2013;94:574-581. [PMID: 23933971 DOI: 10.1038/clpt.2013.157] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 6.8] [Reference Citation Analysis]
145 Lee M, Hong I, Kim M, Lee B, Kim J, Kang K, Kim H, Yoon B, Chung H, Kong G, Lee M. Gene expression profiles of murine fatty liver induced by the administration of methotrexate. Toxicology 2008;249:75-84. [DOI: 10.1016/j.tox.2008.04.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
146 Szabo M, Veres Z, Baranyai Z, Jakab F, Jemnitz K. Comparison of human hepatoma HepaRG cells with human and rat hepatocytes in uptake transport assays in order to predict a risk of drug induced hepatotoxicity. PLoS One 2013;8:e59432. [PMID: 23516635 DOI: 10.1371/journal.pone.0059432] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 4.8] [Reference Citation Analysis]
147 Koffas A, Murray-Lyon IM, Williams R. Azithromycin-induced cholestatic hepatitis. Oxf Med Case Reports 2017;2017:omx027. [PMID: 28580159 DOI: 10.1093/omcr/omx027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
148 Corte CLD, Fachinetto R, Puntel R, Wagner C, Nogueira CW, Soares FAA, Rocha JBT. Chronic Treatment with Fluphenazine Alters Parameters of Oxidative Stress in Liver and Kidney of Rats. Basic & Clinical Pharmacology & Toxicology 2009;105:51-7. [DOI: 10.1111/j.1742-7843.2009.00417.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
149 Cosgrove BD, Alexopoulos LG, Hang TC, Hendriks BS, Sorger PK, Griffith LG, Lauffenburger DA. Cytokine-associated drug toxicity in human hepatocytes is associated with signaling network dysregulation. Mol Biosyst. 2010;6:1195-1206. [PMID: 20361094 DOI: 10.1039/b926287c] [Cited by in Crossref: 51] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
150 Rohilla R, Garg T, Goyal AK, Rath G. Herbal and polymeric approaches for liver-targeting drug delivery: novel strategies and their significance. Drug Delivery 2016. [DOI: 10.3109/10717544.2014.945018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
151 Abboud G, Kaplowitz N. Drug-induced liver injury. Drug Saf. 2007;30:277-294. [PMID: 17408305 DOI: 10.2165/00002018-200730040-00001] [Cited by in Crossref: 197] [Cited by in F6Publishing: 171] [Article Influence: 13.1] [Reference Citation Analysis]